Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Mondobiotech Holding AG Ba RLFT
(Total Views: 1286)
Posted On: 12/30/2020 1:05:52 PM
Post# of 653
Avatar
Posted By: mc67
Re: CaptnAmerca #288
$RLFTF Relief's website updated: "How long will it take the FDA to approve RLF-100™ after top-line data are available?

Assuming that the top-line are positive, the FDA could at that time consider granting EUA, which would permit the drug to be launched in Q1 2021.

A New Drug Application (NDA) submission requesting marketing approval would be filed based on positive top-line results. Full NDA approval could be granted to RLF-100 for the US market by Q3 2021.

The FDA granted RLF-100™ fast track designation, which, among other things, makes RLF-100™ eligible for Priority Review if relevant criteria are met.

Priority Review designation means the FDA’s goal is to take action on an application within 6 months compared to 10 months under standard review.

It would be reasonable to expect Priority Review for applications filed under the Coronavirus Treatment Acceleration Program (CTAP). RLF-100TM is part of this program, which was promulgated by the FDA earlier this year in express response to the emergence of the COVID-19 pandemic."

- Alexandre













(1)
(0)






$MJ



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site